The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121903855 12190385 5 F 2016 20160801 20160318 20160809 PER US-AMGEN-USASL2016030449 AMGEN 48.00 YR A F Y 88.44000 KG 20160809 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121903855 12190385 1 PS ENBREL ETANERCEPT 1 Subcutaneous 50 MG, ONCE WEEKLY Y 1062646 103795 50 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE /wk

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121903855 12190385 1 Rheumatoid arthritis

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
121903855 12190385 Contusion Contusion
121903855 12190385 Drug ineffective
121903855 12190385 Erythema Erythema
121903855 12190385 Head discomfort
121903855 12190385 Hepatic enzyme increased
121903855 12190385 Injection site bruising
121903855 12190385 Injection site erythema
121903855 12190385 Injection site induration
121903855 12190385 Injection site mass
121903855 12190385 Injection site pain
121903855 12190385 Injection site rash
121903855 12190385 Injection site reaction
121903855 12190385 Injection site swelling
121903855 12190385 Injection site warmth
121903855 12190385 Pruritus Pruritus
121903855 12190385 Sinusitis
121903855 12190385 Skin induration Skin induration
121903855 12190385 Swelling

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121903855 12190385 1 201602 0